This article has been updated to include comments from NeoGenomics' earnings call.
NEW YORK (GenomeWeb) – NeoGenomics today reported year over year growth of 159 percent in its second quarter revenues driven by an increase in clinical genetic testing volume.
For the three-month period ended June 30, the company posted revenues of $63.1 million compared with $24.4 million a year earlier.